INDGN - Swing Trade Analysis with AI Signals
Last Updated Time : 19 Sept 25, 2:15 pm
Back to Swing Trade ListSwing Trade Rating: 3.8
📊 Technical & Fundamental Analysis
✅ Strengths
MACD (3.31): Bullish crossover, indicating upward momentum.
Price > DMA50 (₹568) & DMA200 (₹579): Trend support confirmed.
ROCE (16.6%) / ROE (12.6%): Solid capital efficiency.
Debt-to-Equity (0.01): Virtually debt-free, adds financial stability.
FII Holding ↑ (4.80%) & DII Holding ↑ (2.24%): Strong institutional accumulation.
Qtr Profit Var (+38.3%): Robust earnings growth.
⚠️ Risks
P/E (72.5) > Industry PE (51.1): Valuation is stretched.
PEG Ratio (6.95): Expensive relative to growth.
RSI (61.5): Approaching overbought zone.
Volume < Avg Vol: Participation fading—needs confirmation.
PAT Qtr ↓: Sequential decline from ₹54.2 Cr. to ₹45.1 Cr.
52w Index (39.7%): Mid-range, not near breakout or support extremes.
🎯 Optimal Entry Price
Buy Zone: ₹565–₹575
A pullback near DMA levels offers better margin of safety.
Entry should be confirmed with RSI cooling below 58 and MACD sustainment.
🚪 Exit Strategy (If Already Holding)
Target Exit: ₹610–₹625
Resistance zone with ~4–7% swing potential.
Stop Loss: ₹552
Below DMA50 and recent support; protects against downside risk.
Let me know if you'd like a filtered scan of mid-cap pharma setups with stronger volume and lower PEG, or a dynamic exit matrix tailored to your current swing basket. I can also help you build confirmation overlays for momentum trades like this one.
Edit in a page
Back to Swing Trade ListNIFTY 50 - Today Top Swing Trade Stock Picks
NEXT 50 - Today Top Swing Trade Stock Picks
MIDCAP - Today Top Swing Trade Stock Picks
SMALLCAP - Today Top Swing Trade Stock Picks